The company announced it would gladly donate $1,000,000, to a charity of the comedians choice if the product fails to prevent the comedian's hangover.
(PRWEB UK) 3 July 2011
Two young Australian Entrepreneurs issued a $1,000,000 invitation on the company's website, facebook and twitter fan pages, to the creator of "Chappelle's Show", Dave Chappelle. The Aussie company invited the comedian to be the first to try its world best anti-hangover shot, prior to its US,UK and AUS launches.
The company announced it would gladly donate $1,000,000, to a charity of the comedian’s choice if the product fails to prevent the comedian’s hangover. In the event the funny man feels hangover free, the company asks that the comedian shoot and upload two sketch videos on the comedian's YouTube channel, to help the company raise online awareness for alcohol abuse. Around 40% of patients admitted to A&E are diagnosed with alcohol-related injuries or illnesses, many of which result from binge drinking, according to drinkaware.co.uk.
David Khari Webber "Dave" Chappelle is an American comedian, screenwriter, television and film producer, actor, and artist. Chappelle began his first lead role in a film was in Half Baked in 1998. In 2003, he became widely known for his popular sketch comedy television series, Chappelle's Show, which ran until 2006. Comedy Central ranked him forty-third in its list of the 100 greatest stand-up comedians.
Making sure IVY anti-hangover shot hits UK shelves, are Sales Directors AJ Chand and Eddy Valentin, who had this to say about the $1,000,000 invitation: "The sale of IVY comes hand in hand with the responsibility of educating the public about alcohol abuse, and that's what this invitation is about."
TheFeelGoodFactory is an Australian based company. It is the maker of the world's most superior anti-hangover shot IVY, launching in the UK, late August 2011. The company is Co-Founded by self-made millionaire brothers David & Daniel Ivachev, protégés of International Best Seller, and successful Businessman Ronnie Kagan.